Leveraging the Power of the Complement System to Target Glomerular Disease Pathophysiology
Time: 2:00 pm
day: Pre-Conference Focus Day
Details:
- Understand how dysregulation of the complement system contributes to the pathogenesis of C3 Glomerulopathy (C3G) and Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN), highlighting the role of C3 inhibition in addressing these complement-driven kidney diseases.
- Explore the latest developments in targeting complement activity, focusing on emerging therapies that aim to reduce immune-mediated kidney damage and improve outcomes for patients with C3G and IC-MPGN
- Review clinical evidence and ongoing trials that position complement inhibitors as a cornerstone for managing C3G and IC-MPGN, emphasizing personalized approaches to address high unmet medical needs.